Ethylpropyltryptamine
Pharmaceutical compound
From Wikipedia, the free encyclopedia
Ethylpropyltryptamine (EPT), also known as N-ethyl-N-propyltryptamine, is a rarely encountered psychedelic drug in the tryptamine family. It has been identified in illicit products in Japan.[1]
- None
 | |
 | |
| Clinical data | |
|---|---|
| Other names | EPT; N-Ethyl-N-propyltryptamine |
| Drug class | Serotonergic psychedelic; Hallucinogen |
| ATC code |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C15H22N2 |
| Molar mass | 230.355 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Use and effects
EPT was not included nor mentioned in Alexander Shulgin's book TiHKAL (Tryptamines I Have Known and Loved).[2]
Interactions
Chemistry
Analogues
Analogues of EPT include methylethyltryptamine (MET), methylpropyltryptamine (MPT), diethyltryptamine (DET), dipropyltryptamine (DPT), among others.[2]
Society and culture
Legal status
Canada
EPT is not a controlled substance in Canada as of 2025.[3]
United Kingdom
It is illegal to sell, distribute, supply, transport or trade the pharmaceutical drug under the Psychoactive Substances Act of 2016.[4]
United States
EPT is unscheduled[5] but it may be considered an analogue of DMT, which is a Schedule I drug under the Controlled Substances Act. As such, the sale for human consumption could be illegal under the Federal Analogue Act.